JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development
Open Access
- 1 February 1999
- journal article
- research article
- Published by Elsevier in Current Biology
- Vol. 9 (3) , 116-125
- https://doi.org/10.1016/s0960-9822(99)80065-7
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997
- Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3Nature, 1997
- Molecular Cloning and Characterization of a Novel Protein Kinase with a Catalytic Domain Homologous to Mitogen-activated Protein Kinase Kinase KinaseJournal of Biological Chemistry, 1996
- Molecular Cloning of Mitogen-activated Protein/ERK Kinase Kinases (MEKK) 2 and 3Published by Elsevier ,1996
- Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T CellsScience, 1996
- Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartmentImmunity, 1995
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor βScience, 1995
- Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cellsImmunity, 1994
- Lymphocyte responses and cytokinesCell, 1994